Literature DB >> 26212846

Simplified sleep restriction for insomnia in general practice: a randomised controlled trial.

Karen Falloon1, C Raina Elley1, Antonio Fernando2, Arier C Lee3, Bruce Arroll1.   

Abstract

BACKGROUND: Insomnia is common in primary care. Cognitive behavioural therapy for insomnia (CBT-I) is effective but requires more time than is available in the general practice consultation. Sleep restriction is one behavioural component of CBT-I. AIM: To assess whether simplified sleep restriction (SSR) can be effective in improving sleep in primary insomnia. DESIGN AND
SETTING: Randomised controlled trial of patients in urban general practice settings in Auckland, New Zealand.
METHOD: Adults with persistent primary insomnia and no mental health or significant comorbidity were eligible. Intervention patients received SSR instructions and sleep hygiene advice. Control patients received sleep hygiene advice alone. Primary outcomes included change in sleep quality at 6 months measured by the Pittsburgh Sleep Quality Index (PSQI), Insomnia Severity Index (ISI), and sleep efficiency (SE%). The proportion of participants reaching a predefined 'insomnia remission' treatment response was calculated.
RESULTS: Ninety-seven patients were randomised and 94 (97%) completed the study. At 6-month follow-up, SSR participants had improved PSQI scores (6.2 versus 8.4, P<0.001), ISI scores (8.6 versus 11.1, P = 0.001), actigraphy-assessed SE% (difference 2.2%, P = 0.006), and reduced fatigue (difference -2.3 units, P = 0.04), compared with controls. SSR produced higher rates of treatment response (67% [28 out of 42] versus 41% [20 out of 49]); number needed to treat = 4 (95% CI = 2.0 to 19.0). Controlling for age, sex, and severity of insomnia, the adjusted odds ratio for insomnia remission was 2.7 (95% CI = 1.1 to 6.5). There were no significant differences in other outcomes or adverse effects.
CONCLUSION: SSR is an effective brief intervention in adults with primary insomnia and no comorbidities, suitable for use in general practice. © British Journal of General Practice 2015.

Entities:  

Keywords:  behaviour therapy; general practice; sleep initiation and maintenance disorders

Mesh:

Year:  2015        PMID: 26212846      PMCID: PMC4513738          DOI: 10.3399/bjgp15X686137

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


  35 in total

1.  Validation of the Insomnia Severity Index as an outcome measure for insomnia research.

Authors:  C H. Bastien; A Vallières; C M. Morin
Journal:  Sleep Med       Date:  2001-07       Impact factor: 3.492

2.  Patients' acceptance of psychological and pharmacological therapies for insomnia.

Authors:  C M Morin; B Gaulier; T Barry; R A Kowatch
Journal:  Sleep       Date:  1992-08       Impact factor: 5.849

Review 3.  Comparative meta-analysis of behavioral interventions for insomnia and their efficacy in middle-aged adults and in older adults 55+ years of age.

Authors:  Michael R Irwin; Jason C Cole; Perry M Nicassio
Journal:  Health Psychol       Date:  2006-01       Impact factor: 4.267

4.  Prevalence of insomnia in a survey of 12,778 adults in France.

Authors:  D Leger; C Guilleminault; J P Dreyfus; C Delahaye; M Paillard
Journal:  J Sleep Res       Date:  2000-03       Impact factor: 3.981

5.  The PHQ-9: validity of a brief depression severity measure.

Authors:  K Kroenke; R L Spitzer; J B Williams
Journal:  J Gen Intern Med       Date:  2001-09       Impact factor: 5.128

6.  Prevalence and perceived health associated with insomnia based on DSM-IV-TR; International Statistical Classification of Diseases and Related Health Problems, Tenth Revision; and Research Diagnostic Criteria/International Classification of Sleep Disorders, Second Edition criteria: results from the America Insomnia Survey.

Authors:  Thomas Roth; Catherine Coulouvrat; Goeran Hajak; Matthew D Lakoma; Nancy A Sampson; Victoria Shahly; Alicia C Shillington; Judith J Stephenson; James K Walsh; Ronald C Kessler
Journal:  Biol Psychiatry       Date:  2010-12-31       Impact factor: 13.382

Review 7.  Insomnia as a predictor of depression: a meta-analytic evaluation of longitudinal epidemiological studies.

Authors:  Chiara Baglioni; Gemma Battagliese; Bernd Feige; Kai Spiegelhalder; Christoph Nissen; Ulrich Voderholzer; Caterina Lombardo; Dieter Riemann
Journal:  J Affect Disord       Date:  2011-02-05       Impact factor: 4.839

8.  A new method for measuring daytime sleepiness: the Epworth sleepiness scale.

Authors:  M W Johns
Journal:  Sleep       Date:  1991-12       Impact factor: 5.849

9.  Interpreting score differences in the Insomnia Severity Index: using health-related outcomes to define the minimally important difference.

Authors:  Min Yang; Charles M Morin; Kendyl Schaefer; Gene V Wallenstein
Journal:  Curr Med Res Opin       Date:  2009-10       Impact factor: 2.580

10.  Insomnia with objective short sleep duration is associated with a high risk for hypertension.

Authors:  Alexandros N Vgontzas; Duanping Liao; Edward O Bixler; George P Chrousos; Antonio Vela-Bueno
Journal:  Sleep       Date:  2009-04       Impact factor: 5.849

View more
  10 in total

1.  Trouble sleeping: spend less time in bed?

Authors:  G Michael Allan; Adrienne J Lindblad; Jobin Varughese
Journal:  Can Fam Physician       Date:  2017-08       Impact factor: 3.275

2. 

Authors:  G Michael Allan; Adrienne J Lindblad; Jobin Varughese
Journal:  Can Fam Physician       Date:  2017-08       Impact factor: 3.275

3.  Patient Preferences for Managing Insomnia: A Discrete Choice Experiment.

Authors:  Janet M Y Cheung; Delwyn J Bartlett; Carol L Armour; Bandana Saini; Tracey-Lea Laba
Journal:  Patient       Date:  2018-10       Impact factor: 3.883

4.  Effect of wearables on sleep in healthy individuals: a randomized crossover trial and validation study.

Authors:  Sarah Berryhill; Christopher J Morton; Adam Dean; Adam Berryhill; Natalie Provencio-Dean; Salma I Patel; Lauren Estep; Daniel Combs; Saif Mashaqi; Lynn B Gerald; Jerry A Krishnan; Sairam Parthasarathy
Journal:  J Clin Sleep Med       Date:  2020-02-11       Impact factor: 4.062

5.  Use of Actigraphy for the Evaluation of Sleep Disorders and Circadian Rhythm Sleep-Wake Disorders: An American Academy of Sleep Medicine Systematic Review, Meta-Analysis, and GRADE Assessment.

Authors:  Michael T Smith; Christina S McCrae; Joseph Cheung; Jennifer L Martin; Christopher G Harrod; Jonathan L Heald; Kelly A Carden
Journal:  J Clin Sleep Med       Date:  2018-07-15       Impact factor: 4.062

6.  Clustering Insomnia Patterns by Data From Wearable Devices: Algorithm Development and Validation Study.

Authors:  Sungkyu Park; Sang Won Lee; Sungwon Han; Meeyoung Cha
Journal:  JMIR Mhealth Uhealth       Date:  2019-12-05       Impact factor: 4.773

7.  Primary care treatment of insomnia: study protocol for a pragmatic, multicentre, randomised controlled trial comparing nurse-delivered sleep restriction therapy to sleep hygiene (the HABIT trial).

Authors:  Simon D Kyle; Claire Madigan; Nargis Begum; Lucy Abel; Stephanie Armstrong; Paul Aveyard; Peter Bower; Emma Ogburn; Aloysius Siriwardena; Ly-Mee Yu; Colin A Espie
Journal:  BMJ Open       Date:  2020-03-04       Impact factor: 2.692

8.  Investigation of the role of sleep and physical activity for chronic disease prevalence and incidence in older Irish adults.

Authors:  Belinda Hernández; Siobhán Scarlett; Frank Moriarty; Roman Romero-Ortuno; Rose Anne Kenny; Richard Reilly
Journal:  BMC Public Health       Date:  2022-09-09       Impact factor: 4.135

Review 9.  Clinician and patient barriers to the recognition of insomnia in family practice: a narrative summary of reported literature analysed using the theoretical domains framework.

Authors:  Rowan P Ogeil; Samantha P Chakraborty; Alan C Young; Dan I Lubman
Journal:  BMC Fam Pract       Date:  2020-01-04       Impact factor: 2.497

Review 10.  Improving sleep quality leads to better mental health: A meta-analysis of randomised controlled trials.

Authors:  Alexander J Scott; Thomas L Webb; Marrissa Martyn-St James; Georgina Rowse; Scott Weich
Journal:  Sleep Med Rev       Date:  2021-09-23       Impact factor: 11.609

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.